Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2017

01-12-2017 | Hepatobiliary Tumors

Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis

Authors: Erdim Sertoglu, MD, Huseyin Kayadibi, MD, Metin Uyanik, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2017

Login to get access

Excerpt

We read with great interest the article by Shen et al.1 who aimed to evaluate the prognostic value of platelet-based indices, including platelet count, platelet/lymphocyte ratio (PLR), and aspartate aminotransferase (AST) to platelet ratio index (APRI) in hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC) after hepatic resection. In their conclusions, Shen et al. stated that elevated platelet-based inflammatory indices, especially APRI, were found to be associated with adverse characteristic features and poor prognosis in HCC, especially for patients with HBV infection or cirrhosis. However, we would like to share our thoughts and contributions to this study. …
Literature
1.
Shen SL, Fu SJ, Chen B, Kuang M, Li SQ, Hua YP, et al. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection. Ann Surg Oncol. 2014;21(12):3802–9.CrossRefPubMed
2.
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–26.CrossRefPubMed
3.
Sohn W, Jun DW, Kwak MJ, Park Q, Lee KN, Lee HL, et al. Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea. J Gastroenterol Hepatol. 2013;28(3):522-9.CrossRefPubMed
4.
5.
Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC, et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg. 2011;212(4):638–48; discussion 648–50.CrossRefPubMedPubMedCentral
Metadata
Title
Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis
Authors
Erdim Sertoglu, MD
Huseyin Kayadibi, MD
Metin Uyanik, MD
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6228-1

Other articles of this Special Issue 3/2017

Annals of Surgical Oncology 3/2017 Go to the issue

Colorectal Cancer

Comment: Fancier and More Expensive Do Mean Better: An Argument for Computed Tomography Staging of Patients With Colorectal Liver Metastases

Breast Oncology

Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods for the Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer: A Reply

Hepatobiliary Tumors

Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply

Hepatobiliary Tumors

Reply to: Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis

Erratum

Erratum to: Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study

Health Services Research and Global Oncology

The Changing Face of Surgical Oncology